MiMedx Q4 EPS of $0.14 Beats Estimates, Revenues Up 27% to $118.1M
MiMedx reported Q4 adjusted EPS of $0.14, outperforming the $0.09 consensus by 55.6% and up from $0.07 a year earlier. Quarterly revenues rose 27% year-over-year to $118.1 million, surpassing estimates by 14.9%.
1. Q4 Earnings Beat Estimates
MiMedx delivered Q4 adjusted earnings of $0.14 per share, outpacing the $0.09 consensus by 55.6% and up from $0.07 in the year-ago quarter. This marks the third EPS beat in four consecutive quarters.
2. Revenue Growth Details
The company generated $118.1 million in revenue, a 27% increase from $92.9 million a year earlier and 14.9% above analyst expectations. This represents the fourth straight quarter of revenue outperformance.
3. Stock Performance and Outlook
MiMedx shares have declined about 21% since the start of the year versus a 0.7% gain in the S&P 500. Consensus forecasts call for breakeven EPS on $77.5 million of revenue next quarter and $0.13 on $362.5 million for the full fiscal year.